Stylus Medicine had groundbreaking genetic medicine technology and $85M in initial backing, but their minimal web presence wasn't effectively communicating their value to potential investors. Despite impressive science and major backers like Johnson & Johnson and Lilly, their basic online presence was costing them opportunities. Our strategic approach focused on transforming their limited digital footprint into a comprehensive investor-focused platform. We needed to communicate complex science clearly while leveraging their existing credibility signals to attract additional funding rounds. We developed messaging that simplified breakthrough technology into clear investor benefits, created strategic content architecture, and built a complete digital ecosystem. The 'Encoding Health, Unlocking Cures' positioning helped investors immediately understand the transformational potential of precision genetic medicine.